Evidence map›Paper›PMID 42461278›Full record

ArticleInternational urogynecology journal2026

Laser, radiofrequency, and promestriene in the treatment of genitourinary syndrome of menopause in breast cancer survivors: randomized clinical trial.

Chayane Dedonatto, Ana Maria Homem de Mello Bianchi-Ferraro, Rita de Cassia de Maio Dardes, Marair Gracio Ferreira Sartori, LARF- Study group, Marisa Teresinha Patriarca

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chayane DedonattoDepartamento de Ginecologia da Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Botucatu, 740, 5 Andar, São Paulo, 04023-062, Brazil.
Ana Maria Homem de Mello Bianchi-FerraroDepartamento de Ginecologia da Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Botucatu, 740, 5 Andar, São Paulo, 04023-062, Brazil. anamariahmb@yahoo.com.br.
Rita de Cassia de Maio DardesDepartamento de Ginecologia da Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Botucatu, 740, 5 Andar, São Paulo, 04023-062, Brazil.
Marair Gracio Ferreira SartoriDepartamento de Ginecologia da Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Botucatu, 740, 5 Andar, São Paulo, 04023-062, Brazil.
LARF- Study group
Marisa Teresinha PatriarcaDepartamento de Ginecologia da Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Botucatu, 740, 5 Andar, São Paulo, 04023-062, Brazil.

Funding

Fapesp 2019/ 15802-1
6 · The paper itself

Abstract

introduction and hypothesisGenitourinary syndrome of menopause is a chronic and high prevalent condition with a substantial negative impact in women's quality of life and vaginal health. The prevalence of GSMis even higher among breast cancer survivors receiving endocrine adjuvant therapy. This study aimed to evaluate the efficacy and safety of CO

methodsA multi-arm randomized clinical trial enrolled postmenopausal women with breast cancer undergoing endocrine adjuvant therapy. Participants were randomized to receive CO

resultsFifty-eight women completed the treatment and the 10-month follow-up (21 CO

conclusionsCO

Indexed as

Adjuvant endocrine therapyBreast cancer survivorsCO2 laserGenitourinary syndrome of menopausePromestrieneQuality of lifeRadiofrequencyRandomized clinical trialVaginal health

Identifiers

PMID42461278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.